Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lemborexant for Irregular Sleep-Wake Rhythm Disorder in Mild to Moderate Alzheimer's Disease Dementia
2017-003306-40Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lemborexant in Irregular sleep-wake rhythm disorder (ISWRD), Alzheimer's disease (AD), sponsored by Eisai Co., Ltd.. Started Sep 2017; status: completed.
02
Drugs
lemborexant
03
Conditions
Irregular sleep-wake rhythm disorder (ISWRD)Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2017-003306-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-003306-40.